The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase 1 study evaluating ABT-414 in combination with temozolomide (TMZ) for subjects with recurrent or unresectable glioblastoma (GBM).
Hui Kong Gan
Employment or Leadership Position - Ludwig Institute for Cancer Research
Lisa Fichtel
No relevant relationships to disclose
Andrew B. Lassman
Consultant or Advisory Role - Abbott Laboratories; Able Associates; Agenus; Amgen; Defined Health; Easton Associates; GlaxoSmithKline; Kyowa Hakko Kirin; Merck Sharp & Dohme; Novartis; RadMD; Roche/Genentech; Scientific Advisors; Sigma-Tau; Stemline; Synapse; Venture Inflections
Honoraria - American Physician Inst; Merck Sharp & Dohme; OmniPrex America; Robert Michael Educational Inst
Research Funding - AbbVie; Agenus; Amgen; Boehringer Ingelheim; Celldex; Genentech; MedImmune; Northwest Biotherapeutics; Novartis; NPM Pharma; Pfizer; Plexxikon
Ryan Merrell
No relevant relationships to disclose
Martin J. Van Den Bent
Consultant or Advisory Role - AbbVie; Actelion; Amgen; Celldex; MSD; Roche
Research Funding - AbbVie; Roche
Priya Kumthekar
No relevant relationships to disclose
Andrew Mark Scott
Employment or Leadership Position - Ludwig Institute for Cancer Research
Consultant or Advisory Role - Life Science Pharmaceuticals (U)
Stock Ownership - Life Science Pharmaceuticals
Michelle Pedersen
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Erica Gomez
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
JuDee Fischer
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
William Ames
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Hao Xiong
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Matthew W. Dudley
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Wijith Munasinghe
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Lisa Roberts-Rapp
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Peter Ansell
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
Kyle D. Holen
Employment or Leadership Position - AbbVie
Stock Ownership - AbbVie
David A. Reardon
Consultant or Advisory Role - Amgen; Momenta Pharmaceuticals; Novartis; Roche; Stemline Therapeutics
Honoraria - Amgen; Merck; Momenta Pharmaceuticals; Novartis; Roche; Stemline Therapeutics